These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 24958857)
1. STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression. Turnquist C; Wang Y; Severson DT; Zhong S; Sun B; Ma J; Constaninescu SN; Ansorge O; Stolp HB; Molnár Z; Szele FG; Lu X Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9834-9. PubMed ID: 24958857 [TBL] [Abstract][Full Text] [Related]
2. ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63. Tordella L; Koch S; Salter V; Pagotto A; Doondeea JB; Feller SM; Ratnayaka I; Zhong S; Goldin RD; Lozano G; McKeon FD; Tavassoli M; Fritzsche F; Huber GF; Rössle M; Moch H; Lu X Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17969-74. PubMed ID: 24127607 [TBL] [Abstract][Full Text] [Related]
3. Deficiency of apoptosis-stimulating protein two of p53 ameliorates acute kidney injury induced by ischemia reperfusion in mice through upregulation of autophagy. Ji J; Zhou X; Xu P; Li Y; Shi H; Chen D; Li R; Shi H J Cell Mol Med; 2019 Apr; 23(4):2457-2467. PubMed ID: 30675758 [TBL] [Abstract][Full Text] [Related]
4. ASPP2 binds Par-3 and controls the polarity and proliferation of neural progenitors during CNS development. Sottocornola R; Royer C; Vives V; Tordella L; Zhong S; Wang Y; Ratnayaka I; Shipman M; Cheung A; Gaston-Massuet C; Ferretti P; Molnár Z; Lu X Dev Cell; 2010 Jul; 19(1):126-37. PubMed ID: 20619750 [TBL] [Abstract][Full Text] [Related]
5. Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription. Piaszyk-Borychowska A; Széles L; Csermely A; Chiang HC; Wesoły J; Lee CK; Nagy L; Bluyssen HAR Front Immunol; 2019; 10():1253. PubMed ID: 31231385 [TBL] [Abstract][Full Text] [Related]
6. ASPP2 regulates epithelial cell polarity through the PAR complex. Cong W; Hirose T; Harita Y; Yamashita A; Mizuno K; Hirano H; Ohno S Curr Biol; 2010 Aug; 20(15):1408-14. PubMed ID: 20619648 [TBL] [Abstract][Full Text] [Related]
7. ASPP2: a gene that controls life and death in vivo. Vives V; Slee EA; Lu X Cell Cycle; 2006 Oct; 5(19):2187-90. PubMed ID: 16969108 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation. Chen R; Wang H; Liang B; Liu G; Tang M; Jia R; Fan X; Jing W; Zhou X; Wang H; Yang Y; Wei H; Li B; Zhao J Cell Death Dis; 2016 Dec; 7(12):e2512. PubMed ID: 27929538 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene. Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436 [TBL] [Abstract][Full Text] [Related]
10. New insights into the expanding complexity of the tumor suppressor ASPP2. Kampa KM; Bonin M; Lopez CD Cell Cycle; 2009 Sep; 8(18):2871-6. PubMed ID: 19657229 [TBL] [Abstract][Full Text] [Related]
11. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2). Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740 [TBL] [Abstract][Full Text] [Related]
12. Siah2 regulates tight junction integrity and cell polarity through control of ASPP2 stability. Kim H; Claps G; Möller A; Bowtell D; Lu X; Ronai ZA Oncogene; 2014 Apr; 33(15):2004-10. PubMed ID: 23644657 [TBL] [Abstract][Full Text] [Related]
13. Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism. Rotem-Bamberger S; Katz C; Friedler A PLoS One; 2013; 8(3):e58470. PubMed ID: 23472201 [TBL] [Abstract][Full Text] [Related]
14. Deficiency of apoptosis-stimulating protein two of p53 promotes liver regeneration in mice by activating mammalian target of rapamycin. Shi H; Zhang Y; Ji J; Xu P; Shi H; Yue X; Ren F; Chen Y; Duan Z; Chen D Sci Rep; 2018 Dec; 8(1):17927. PubMed ID: 30560875 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Zhao J; Wu G; Bu F; Lu B; Liang A; Cao L; Tong X; Lu X; Wu M; Guo Y Hepatology; 2010 Jan; 51(1):142-53. PubMed ID: 20034025 [TBL] [Abstract][Full Text] [Related]
16. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways. Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645 [TBL] [Abstract][Full Text] [Related]
17. A model for the interaction between NF-kappa-B and ASPP2 suggests an I-kappa-B-like binding mechanism. Benyamini H; Leonov H; Rotem S; Katz C; Arkin IT; Friedler A Proteins; 2009 Nov; 77(3):602-11. PubMed ID: 19507243 [TBL] [Abstract][Full Text] [Related]
18. ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Vives V; Su J; Zhong S; Ratnayaka I; Slee E; Goldin R; Lu X Genes Dev; 2006 May; 20(10):1262-7. PubMed ID: 16702401 [TBL] [Abstract][Full Text] [Related]
19. [Effect of overexpression of apoptosis-stimulating protein 2 of p53 on activation and apoptosis of hepatic stellate cells induced by transforming growth factor-β1 and its mechanism]. Lin MH; Guo XH; Qiao LX; Xie F; Shi Y Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):890-895. PubMed ID: 31941245 [No Abstract] [Full Text] [Related]
20. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors. Dreyfus DH; Nagasawa M; Gelfand EW; Ghoda LY BMC Immunol; 2005 Jun; 6():12. PubMed ID: 15969767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]